Pharmacelsus’ GLP implementation exemplary for European CROs
During a three days hands-on training, they glanced at the lab-life in theory and practice, especially focusing the GLP relevant implementation on in vitro toxicology and bioanalytics. The practical course provided the opportunity for staff of all levels to understand the importance and relevance of GLP compliance, and how to apply the requirements of GLP into their everyday work in an in vitro laboratory.
Pharmacelsus cooperates with ECVAM in the framework of an international pre-validation study in the field of human metabolism and toxicity which is supervised by ECVAM.
Pharmacelsus holds the statement of GLP compliance for categories 2 (toxicity studies), 8 (analytical and clinical chemistry testing) and 9 (other studies: pharmacodynamic, pharmacokinetic, metabolical and toxicological testing). Because of the GLP status, the company is now able to perform accompanying analytical services for clinical studies in addition to its preclinical services.
Most read news
Other news from the department politics & laws
These products might interest you
Genomics & Analytical Services by Azenta
Integrated Genomics & Analytical Services from Azenta Life Sciences
Discovery can be challenging work. Until you find the right genomics partner.
Pharmaceutical Development Services by AR2i
Take Advantage of AR2i's Analytical Knowledge and Unique Expertise
Our Pharmaceutical Laboratory Services According to the European Pharmacopoeia or Client Needs
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.